Senior Director, Intellectual Property
Cambridge, MA
Legal /
Fulltime /
On-site
Summary
As Senior Director, Intellectual Property, you will serve as a key legal advisor and strategic partner to our R&D, CMC, and Tech Ops teams. You will be responsible for all aspects of IP management, including patent prosecution, freedom-to-operate analysis, competitive IP intelligence, IP litigation, and IP-related transactions, with a focus on technologies central to radioligand therapies such as ligand design, radionuclide conjugation, isotope production, and radiochemistry.
Key Responsibilities
- Develop and implement IP strategies for protecting innovations across the RLT platform, including ligands, chelators, linkers, isotopes, targeting vectors, and manufacturing processes
- Manage and grow the company’s global patent portfolio, including drafting and prosecution
- Conduct and supervise freedom-to-operate (FTO), patentability, and landscape analyses in collaboration with R&D and corporate strategy
- Provide strategic IP input into clinical and regulatory activities, including IND and BLA submissions, and assess potential third-party IP risks
- Manage and provide strategic direction on all IP litigation, including actions before the USPTO and oppositions
- Advise on IP-related aspects of business development, including due diligence for licensing, collaboration, and acquisition opportunities
- Manage and collaborate with external patent counsel and ensure timely and cost-effective handling of IP matters
- Draft, review, and negotiate IP provisions in agreements, including licensing, collaborations, sponsored research, MTAs and CDAs
- Train and inform scientists and senior management on IP awareness and strategy
- Provide support and gain experience on legal matters outside of IP including contracts, corporate governance, employment, and business development transactions.
- Travel to Oslo, Norway as needed
Qualifications
- J.D. from an accredited law school and admission to practice in at least one U.S. jurisdiction
- Registered to practice before the U.S. Patent and Trademark Office (USPTO)
- 5–10+ years of relevant experience in patent law, with strong exposure to the biopharma industry
- Ph.D. in chemistry, radiochemistry, biochemistry, bioengineering, or a related life science discipline is preferred
- Experience with radiopharmaceuticals is highly desirable
- Demonstrated ability to align IP strategy with scientific, clinical and commercial goals in a fast-paced, innovative environment
Preferred Experience
- Prior law firm experience
- In-house experience at a biotech or pharmaceutical company
- Knowledge of isotope supply chains, CMO partnerships, and manufacturing of radiopharmaceuticals
- Strong cross-cultural communication skills and the ability to adapt to a dynamic international team setting
- Experience with patent law in jurisdictions outside of the U.S.
About Us
ARTBIO is re-defining cancer care by developing a new class of radioligand therapies (RLT) which harness the power of 212Pb and deliver it directly to the tumour. Targeted RLT is one of the fastest growing areas of oncology research and investment. The foundational technology, termed AlphaDirect, was born out of elegant research by our scientific founders, Roy Larsen and Øyvind Bruland, inventors of XofigoTM. ARTBIO is leveraging this groundbreaking science and expediting novel drug discovery targets which broadly exploit the unmet medical need and opportunity in revolutionising cancer care. Supported by a committed group of investors, ARTBIO has built a highly experienced, multi-disciplinary team of drug-hunters and developers. For more information on our strategy and emerging pipeline, please visit www.artbio.com and follow-us on LinkedIn.
As an emerging, global biotech with locations in Cambridge, Massachusetts, Basel, Switzerland, London, England and Oslo, Norway, we take advantage of diverse scientific depth and insights which makes ARTBIO a unique place to work. We are driven by a desire to do better for cancer patients, lowering the burden of toleration and safety while at the same time raising the bar on clinical efficacy and duration.
EEO Statement
ARTBIO is proud to be an equal opportunity workplace and is an affirmative action employer. We are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or veteran status. If you have a disability or special need that requires accommodation, please let us know.
Questions and Application Process
If interested, please apply and send your CV to HR@artbio.com; All inquiries are treated confidentially.
